FINWIRES · TerminalLIVE
FINWIRES

Oil Prices Rebound as Optimism Around US-Iran Truce Wanes

-- Oil prices increased Thursday, with US crude crossing $100 a barrel as shipment activity through the Strait of Hormuz remained restricted despite a two-week ceasefire between Washington and Iran.

West Texas Intermediate crude traded as much as $102.70 a barrel on Thursday, and was last up 3.4% at $97.57. Brent crude climbed 0.9% to $95.61, having hit $99.50 earlier in the session.

The rebound in oil prices follows the sharpest one-day pullback since 2020 in the previous session as the US and Iran agreed to temporarily halt hostilities that had gripped the Middle East.

As part of the ceasefire, Washington demanded the immediate opening of the Strait of Hormuz, while Tehran said it would allow "safe passage" through the crucial waterway, subject to coordination with Iranian authorities.

But access to the strait remained restricted, Abu Dhabi National Oil Co. Chief Executive Sultan Al Jaber said in a LinkedIn post Thursday.

"The Strait of Hormuz is not open. Access is being restricted, conditioned and controlled," said Al Jaber, who also serves as the United Arab Emirates minister of industry and advanced technology.

Iranian state media previously reported that transit through the strait was halted following Israeli attacks on Lebanon. Israeli Prime Minister Benjamin Netanyahu said the country would negotiate with Lebanon on disarming Hezbollah, CNN reported on Thursday.

Meanwhile, Gulf countries, including the UAE, continued to face attacks despite the ceasefire, RBC Capital Markets said in a report e-mailed toon Thursday.

"We continue to contend that actual transit levels through the waterway will remain significantly depressed given that Iran is insisting vessels must coordinate with its military or face destruction," Helima Croft, head of global commodity strategy at RBC, said.

Officials from Washington and Tehran are expected to meet this weekend in Pakistan, which helped broker the truce.

Overnight, President Donald Trump said in a post on Truth Social that US ships, aircraft and military personnel will remain in and around Iran until the "real agreement reached is fully complied with."

"With a full reopening of the strait unlikely in the near term, oil prices are expected to remain supported, as disruptions linked to reduced output and refinery shutdowns will take time to unwind," ING Bank said in a note.

相关文章

Australia

主要加密货币下跌;比特币跌破75000美元

周二,主流加密货币普遍下跌,其中比特币(BTC-USD)跌破75,000美元关口。 追踪包括比特币在内的数十种数字资产的CoinDesk市场指数在过去24小时内下跌近0.6%。纳斯达克100指数下跌0.5%,标普500指数和道琼斯工业平均指数均下跌约0.6%。 根据CoinMarketCap的数据,比特币下跌1.7%至74,985美元。这种最受欢迎的加密货币的24小时交易量下降7.1%至371亿美元。 市值排名第二的数字资产以太坊(ETH-USD)下跌1.4%至2,297美元。 瑞波币(XRP-USD)下跌1%,币安币(BNB-USD)下跌0.7%,索拉纳币(SOL-USD)下跌1.6%。狗狗币 (DOGE-USD) 下跌 1.6%,卡尔达诺 (ADA-USD) 也下跌 1.6%。 美国 10 年期国债收益率于周二下午 3 点(美东时间)报 4.289%,高于周一的 4.248%;5 年期国债收益率则从 3.848% 升至 3.906%。 过去 24 小时内,加密货币行业总市值下跌 0.6% 至 2.55 万亿美元,交易量下降 1.5% 至 1533.7 亿美元。Price: $74991.13, Change: $-863.67, Percent Change: -1.14%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Sectors

行业动态:金融股午后回落

周二下午晚些时候,金融股普遍下跌,纽约证券交易所金融指数下跌0.6%,道富金融精选行业SPDR ETF(XLF)下跌0.3%。 费城住房指数上涨0.8%,道富房地产精选行业SPDR ETF(XLRE)下跌1.6%。 比特币(BTC-USD)下跌0.2%至75,717美元,10年期美国国债收益率上涨4.2个基点至4.29%。 经济方面,美国3月份零售销售额增长1.7%,高于彭博社调查预期的1.4%,也高于上月修正后的0.7%的增幅。剔除机动车销售和加油站销售额15.5%的激增后,3月份零售销售额增长0.6%,与2月份持平。 美国全国房地产经纪人协会的数据显示,尽管抵押贷款利率上升,但3月份美国待售房屋数量仍超出预期。 企业新闻方面,据彭博社报道,摩根大通(JPM)正努力获得中国证券监管机构的批准,计划首次在中国推出主动管理型交易所交易基金(ETF)。摩根大通股价下跌1.3%。 据路透社报道,纽约州总检察长莱蒂西亚·詹姆斯(Letitia James)已对Coinbase(COIN)和Gemini Titan提起诉讼,指控其预测市场涉嫌违反纽约州禁止非法赌博的法律。路透社援引曼哈顿州法院提交的诉状称,Coinbase股价下跌超过7%。 华盛顿信托银行(WASH)周一晚间公布,其第一季度营收同比下降,且低于分析师预期。其股价暴跌近17%。 据彭博社报道,巴克莱银行(BCS)正因其使用重大风险转移(SRT)交易而受到英国监管机构的审查。报道称,此次审查(即《监管法》第166条调查)是由英国审慎监管局(PRA,英格兰银行的监管机构)要求进行的。巴克莱银行股价下跌2.9%。

$BCS$COIN$JPM$WASH
Sectors

板块动态:医疗保健股午后走软

周二下午晚些时候,医疗保健类股下跌,纽约证券交易所医疗保健指数下跌1%,道富医疗保健精选行业SPDR ETF (XLV)下跌0.9%。 iShares生物科技ETF (IBB)下跌1%。 公司新闻方面,美国监管机构告知Passage Bio (PASG),其实验性疗法PBFT02需要进行一项随机对照试验才能获得批准,此举将增加时间、成本和不确定性,令该公司面临更加艰难的处境。Wedbush周二在一份报告中指出,Wedbush将Passage Bio的股票评级从“跑赢大盘”下调至“中性”,并将目标价从32美元下调至8美元。Passage Bio股价下跌2.9%。 默克(MRK)和日本医疗保健公司卫材(Eisai)周二表示,两款药物组合的3期临床试验未能达到主要终点,即无进展生存期和总生存期,作为晚期透明细胞肾细胞癌的一线治疗方案,其疗效与Keytruda联合Lenvima相比逊于后者。默克股价下跌3.7%。 联合健康集团(UNH)周二上调了全年盈利预期,此前这家健康保险巨头公布的第一季度业绩意外实现年度增长。其股价应声上涨超过7%。 奎斯特诊断公司(DGX)公布第一季度调整后盈利和净收入均有所增长,并上调了2026年业绩预期,受此消息提振,其股价上涨超过4%。

$DGX$MRK$PASG$UNH